SCHEMBL30963554

SCHEMBL30963554

Cc1ccc(C)n1-c1nnc(-n2nccc2I)s1

nearest known ligand 0.35

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.35
MAPT P10636 12/20 0.33
TSHR P16473 1/20 0.33
GPX4 P36969 2/20 0.32
TP53 P04637 2/20 0.32
RXFP1 Q9HBX9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30963570 0.85 POLB (0.37) POLBMAPTTSHRGPX4TP53
SCHEMBL30963427 0.81 POLB (0.35) POLBMAPTTSHRGPX4TP53
SCHEMBL30963528 0.78 GPX4 (0.38) POLBMAPTGPX4TP53RXFP1
SCHEMBL31201073 0.78 ALDH1A1 (0.36) POLBMAPTTP53
SCHEMBL30963488 0.77 GPX4 (0.37) POLBMAPTGPX4TP53RXFP1
SCHEMBL30963611 0.77 POLB (0.36) POLBMAPTTP53RXFP1
SCHEMBL30963579 0.77 POLB (0.33) POLBMAPTTP53
SCHEMBL30963449 0.73 POLB (0.41) POLBMAPTTP53RXFP1
SCHEMBL31201096 0.72 POLB (0.37) POLBMAPTGPX4TP53RXFP1
SCHEMBL30963402 0.69 ALDH1A1 (0.39) POLBMAPTTSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651944-A1 INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF Ventus Therapeutics U.S., Inc. (US) 2025-11-26 EP disclosed
EP-4638446-A1 THIADIAZOLE DERIVATIVES AS INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF Ventus Therapeutics U.S., Inc. (US) 2025-10-29 EP disclosed
WO-2024233767-A1 INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2024-11-14 WO disclosed
WO-2024137607-A1 THIADIAZOLE DERIVATIVES AS INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2024-06-27 WO disclosed